Betaglycan (Tgfbr3) is a coreceptor for transforming growth factor-beta (TGFB) superfamily ligands. In the current study, a defect in seminiferous cord formation was detected in 12.5-13.5 days postcoitum (dpc) betaglycan null murine testis. Immunohistochemistry with antibodies against cell-specific markers revealed defects in somatic cell populations. To confirm these data, quantitative real-time PCR was performed to determine changes in the expression levels of genes involved in fetal testis cell differentiation and function. The expression levels of the Leydig cell markers Insl3, Cyp17a1, Cyp11a1, Star, and Hsd3b1 were reduced in knockout testis compared to wild-type testis, beginning at 12.5 dpc. Whole mount in situ hybridization confirmed that Cyp11a1 expression was reduced in the null testis, but its distribution pattern was unchanged. Apoptosis was not affected by the loss of betaglycan, but proliferation within the interstitium was reduced at 14.5 dpc. However, morphometric analysis showed no changes in Leydig cell counts between the wild-type and the knockout testes at 14.5 dpc, indicating that fetal Leydig function, rather than number, was affected by the loss of betaglycan. The expression levels of Sertoli cell markers Dhh, Sox9, and Amh were also reduced in the knockout testis at 14.5 dpc. However, the expression of fetal germ cell markers Pou5f1 and DDX4 were not changed across the genotypes at any age examined. Our data show that the presence of betaglycan is required for normal cord formation, normal fetal Leydig cell development, and the establishment of fetal testis endocrine function, thus implicating TGFB superfamily members as regulators of early fetal testis structure and function.
INTRODUCTION
Gonadogenesis is a highly regulated and unique process in which the genital ridges have the ability to develop into testes or ovaries according to the genetic cues they receive. The bipotential gonad is directed to become testis by the gene encoding the sex-determining gene on the Y chromosome (Sry). If present, Sry turns on a cascade of gene expression in the cells of the undifferentiated gonad, resulting in the expression of genes like Sry-type high mobility group box 9 (Sox9), Anti-Müllerian hormone (Amh), and genes for the steroid enzymes responsible for synthesizing testosterone. AMH and testosterone are both required for normal secondary sexual development and reproductive capacity. Disturbances in the initial sex determination step or later during testes differentiation result in incomplete sexual development and underlie childhood and adult diseases [1] . Of particular prevalence is a group of human disorders categorized under the term ''testicular dysgenesis syndrome,'' which occur in 1 out of every 100 live births [2] . Testicular dysgenesis syndrome includes abnormal spermatogenesis, testicular cancer, cryptorchidism (undescended testes), and hypospadias (abnormal location of the orifice of the urethra). These clinical problems may have a common etiology, originating in early fetal life as a result of poor testis development due to genetic and/or environmental influences [3] . Specifically, it is proposed that a deficiency in androgen production or function by fetal Leydig cells during testis development plays a role in the origin of downstream disorders. In support of this hypothesis, compromised Leydig cell function is associated with low sperm counts and infertility [4] and testicular carcinoma in situ in adult men [5] .
Specific growth factors have been implicated in the regulation of morphological events within the developing urogenital system. The transforming growth factor-beta (TGFB) superfamily is a multifunctional group of growth factors that includes the TGFBs, activins, inhibins, growth and differentiation factors, and bone morphogenetic proteins. Based on loss-of-function mutations in mice, several members of this superfamily participate in the regulation of many cellular events underlying gonad development and function, including cellular proliferation, differentiation, adhesion, and migration [6] [7] [8] . TGFB superfamily signaling is mediated by pairs of serine/threonine kinase receptors that form heteromeric complexes in which the type II receptor is necessary for binding ligand and the type I receptor is necessary for signal transduction [9] . In addition, TGFBR3, commonly known as betaglycan, is a coreceptor for the TGFB superfamily. Betaglycan binds all three TGFB isoforms and inhibins with high affinity and modulates the association of these ligands with the TGFB, bone morphogenetic protein, and activin type II receptors [9] [10] [11] . The introduction of betaglycan into cells that normally lack its expression increases the binding of TGFB ligands to their signaling receptors and has been shown to enhance their activities, particularly those of TGFB2 [12] [13] [14] and inhibins [15] . We have recently shown that in the fetal mouse testis, betaglycan is predominantly localized to cells in the coelomic epithelium, coelomic vessel, and within the testis interstitium, particularly in Leydig cells [16] . Although betaglycan (Tgfbr3) null mice die between 17 and 18.5 days postcoitum (dpc) due to defects in heart and liver development [14] , we noted a disruption to the architecture of fetal testis at the time of sex determination [16] . The current work seeks to clarify the function of betaglycan in the fetal testis by determining how the absence of betaglycan affects the development of the testis at the molecular and cellular levels. Our data demonstrate that the loss of betaglycan expression in fetal testis results in changes in testis cord development at the time of sex determination and compromises fetal Leydig cell function.
MATERIALS AND METHODS

Tissue Collection and Processing
Betaglycan wild-type, heterozygote, and null mouse embryos were obtained from timed matings of betaglycan heterozygote mice (C57BL6 3 129/Sv background). Embryos were dissected from pregnant dams at 11.5-14.5 dpc, with noon on the day of vaginal plugging designated as 0.5 dpc, and genotyped as previously described [14] . All animal handling and experimental procedures were carried out in accordance with the guidelines stipulated and approved by the Monash Medical Centre Animal Ethics Committee. Embryos were sexed by morphology and PCR [16] . For real-time PCR, gonads were dissected away from mesonephroi and frozen at À808C until the RNA was extracted. For histology, urogenital systems were isolated from the embryos and were fixed with Bouins solution for 5 h or with 4% paraformaldehyde overnight, then washed with 70% ethanol. After fixation, samples were dehydrated and embedded in paraffin. Serial sections (4 lm) were collected on Superfrost slides. For histological evaluation, every tenth section of the embryonic gonads was stained with hematoxylin-eosin.
Real-Time Polymerase Chain Reaction Analysis
Gonads were dissected free from the mesonephroi of fetal mice, collected, and separated according to sex and genotype. Independently collected sets of betaglycan knockout, heterozygous, and wild-type ovary and testis at 11.5, 12.5, 13.5, and 14.5 dpc were tested. At least three different sets of cDNA pools from each age were used to perform replicates, each comprising three to four pairs of gonads from each sex. Total RNA was extracted from gonad pools using the RNeasy kit (Qiagen), as recommended by the manufacturer's protocol. Contaminating DNA was removed from the RNA preparations using the DNA-free kit (Ambion). Extracted RNA was quantified using the ND-1000 Nanodrop spectrophotometer (NanoDrop Technologies Inc.). RNA quality and integrity were verified by agarose gel electrophoresis on an Experion instrument (BioRad). Complementary DNA was synthesized from 250 ng of RNA using Expand Reverse Transcriptase (Roche) and random hexamer and oligo d(T)20 primers, as previously described [17] . Quantitative real-time PCR (qRT-PCR) analysis was performed to determine changes in the expression levels of key somatic and germ cell markers and steroidogenic enzymes. PCR samples were prepared to a final volume of 10 ll using the Applied Biosystems ABI SYBR mix (Scoresby). PCR was performed using the Applied Biosystems ABI 7900 HT Fast real-time machine. Cycling conditions consisted of a 10-min initial denaturation step at 958C, then 55 cycles of denaturing (958C for 15 sec), annealing (558C or 618C for 5 sec), and elongation (728C for 8 sec, followed by 798C for 10 sec). Data collection was captured (958C for 15 sec and 798C for 10 sec) to eliminate primer dimers from the analysis. PCR products were detected at 24-35 cycles, but a high number of cycles was used to ensure water controls were not contaminated. PCR reactions were performed in triplicate with negative controls, where water was used in place of the reverse-transcribed template, included for each primer pair to exclude PCR amplification of contaminating DNA. The primers used for qRT-PCR are summarized in Table 1 [18] [19] [20] [21] [22] [23] . A PCR product was amplified for each set of primers, purified using Qiagen spin column set (Qiagen), quantified using the ND-1000 Nanodrop spectrophotometer, and verified by sequencing.
The PCR product was then diluted from 500 fg to 0.5 fg and was used in real-time runs as a standard for quantitative analysis. Analysis was performed as described [24] .
Immunohistochemistry and Immunofluorescence
Immunohistochemistry was performed as previously described [17, 25] . Antigen retrieval was performed in 50 mM glycine pH 3.5, maintained at 908C 154 for 10 min. Polyclonal primary antibodies against CYP11A1 (P450-cholesterol side chain cleavage; CYP11A1; Abcam, ab1294; 1:800); AMH (Santa Cruz, sc-6886; 1:400); SOX9 (Santa Cruz, sc-20095; 1:100); DDX4 (Abcam DDX4/ MVH ab13840; 1:800); proliferating cell nuclear antigen (DAKO mouse monoclonal PCNA, M0879; 1:800), and active caspase 3 (R&D Systems, AF-835; 1:500) were applied for overnight incubation in 0.1% bovine serum albumin/PBS. Subsequent steps were performed at room temperature, with PBS washes between incubations. Biotinylated goat anti-rabbit (CYP11A1, SOX9, DDX4, active caspase 3), sheep anti mouse (PCNA), and rabbit anti-goat secondary antibodies (AMH) were used at 1:500 for 1 h, and then the Vectastain Elite ABC kit was used according to the manufacturer's instructions (Vector Laboratories). Antibody binding was detected as a brown precipitate following development with 3,3 0 -diaminobenzidine tetrahydrochloride, and Harris Hematoxylin was used as counterstain. The sections were mounted under glass coverslips in Depex (BDH Laboratory Supplies). To detect laminin, immunofluorescent staining was performed as previously described [16] using a laminin polyclonal antibody (Sigma, L9393; 1:1000) and a goat anti-rabbit secondary antibody conjugated to Alexa Fluor 568 (Molecular Probes). To assess cell proliferation and apoptosis, at least three littermate pairs at 12.5, 13.5, and 14.5 dpc were examined in at least three independent assays. For apoptosis, counts of active caspase 3-immunopositive cells were performed across each testis section and expressed as mean 6 SD per genotype. For cell proliferation, cords and interstitium were assessed separately, and a minimum of 100 cells/region were counted per embryo. These data are expressed as the percentage (mean 6 SD) of total cells that were unstained (i.e., not proliferating) at 14.5 dpc.
Whole Mount In Situ Hybridization
Whole mount in situ hybridization was carried out as previously described on whole embryos [26] . Briefly, embryos from 12.5 to 14.5 dpc were dissected, fixed overnight in paraformaldehyde, and then taken into a methanol gradient and processed as previously described. Both antisense and sense (negative control) cRNAs were used in every experiment. Cyp11a1 probe was a kind gift from Professor Andrew Sinclair's laboratory (Murdoch Children's Research Institute, Melbourne, Australia).
Morphometric Analysis
Whole testes fixed in Bouins and embedded in paraffin were serially sectioned at 4 lm. The total number of sections was recorded, and every tenth slide was used in immunohistochemistry using a CYP11A1 antibody as described in the previous section. Total gonad areas, cord areas, and Leydig cell numbers per testis section were measured using Professional AnalySIS software (Olympus). Leydig cells were identified as the CYP11A1 positive cells with oval-shaped nucleus and brown-stained heterochromatin granules. Analysis was performed on wild-types (n ¼ 3) and Tgfbr3 knockout littermates (n ¼ 3). The percentage of interstitial area per section was calculated as the difference between total area and total cord area. Leydig cell number per square micrometer was calculated as percentage per interstitial area.
Statistical Analysis
Statistical analyses were conducted using GraphPad Prism (v.4, GraphPad Software Inc.). Means of the real-time PCR data were compared using ANOVA followed by posthoc Tukeys multiple comparisons test. Means of cell counts were compared using two-tailed t-tests. A P-value of 0.05 or less was considered significant.
RESULTS
Betaglycan Null Testis Exhibits Disrupted Cord Formation
Following transient Sry expression around 11.5 dpc in the mouse, the testis differentiates rapidly, and key structural elements such as the testis cords and male-specific vasculature are established by 12.5 dpc [27] . Between 12.5 and 13.5 dpc, the betaglycan null testis displays an aberrant phenotype (Fig.  1) . In wild-type testis, testis cords are visible in whole mount and sections of testis from 12.5 dpc, separated by interstitial cells (Fig. 1, A and B) . In contrast, betaglycan null cords at 12.5-13.5 dpc are poorly formed, not clearly delineated from the surrounding interstitium, and disorganized (Fig. 1, A and  B) . During normal testis development, as the testis forms, Sertoli and peritubular cells establish a basal lamina that surrounds each cord. Assessment of laminin deposition in the betaglycan null testis revealed that the basal lamina of the cords was thinner and discontinuous compared to wild-type testis (Fig. 1C) . By 14.5 dpc, seminiferous cords had formed in the betaglycan null testis (see, e.g., Fig. 2, C and D) , indicating that the dysgenic cord phenotype is transient and associated with the time of sex determination. The severity of these phenotypes varied in the nulls, presumably due to the mixed genetic background of the mouse line. Heterozygote testis sometimes exhibited a mild cord phenotype (see, e.g., Fig. 5 ), but generally the heterozygotes resembled wild-type morphology. Betaglycan null and heterozygous ovaries did not exhibit any overt morphological phenotypes between 12.5 to 14.5 dpc (data not shown).
Apoptosis was a rare event in both wild-type and null testis between 12.5 to 14.5 dpc, with an average of 2.16 6 2.7 and 2.24 6 2.2 apoptotic cells per wild-type and null testis sections, respectively. In contrast, abundant mitotic cells were detected in both the wild-type and betaglycan knockout embryonic testes, with similar levels of staining observed between the genotypes at 12.5-13.5 dpc (data not shown). At 14.5 dpc (Fig. 1D) , 28.2% 6 9.0% and 40.9% 6 19.8% of total cells in the wild-type and null cords, respectively, lacked PCNA staining and were considered to be nonproliferating (P ¼ 0.08). In contrast, betaglycan null testes had significantly fewer proliferating interstitial cells compared to wild types (P ¼ 0.024), with 27.1% 6 5.9% and 44.4% 6 21.9% of cells unstained in the wild-type and null interstitium, respectively.
Betaglycan Null Testis Exhibits Altered Somatic Cell Organization
To determine which cell types were affected by the dysgenesis in the betaglycan null testis, we examined cell-type specific markers in 12.5-14.5 dpc betaglycan wild-type and null testis sections by immunohistochemistry. Immunostaining for the Sertoli cell markers SOX9 and AMH revealed that the cellular arrangements within the cords of the null testis were abnormal, with germ cells clustering in the middle of the cords and Sertoli cells irregularly arranged around the cord borders (Fig. 2, A and B) . Immunostaining for DDX4, a fetal germ cell marker also know as mouse vasa homolog, indicated no overt defects (e.g., changes in the intensity of staining) in germ cells in null testis cords (Fig. 2C) . In contrast, within the interstitium, CYP11A1 immunostaining within fetal Leydig cells was reduced in the betaglycan null testes when compared to age-matched wild-type testes (Fig. 2D) .
To confirm and extend the immunohistochemistry data, the expression levels of cell type-specific genes were examined within testis between 12.5 to 14.5 dpc using qRT-PCR. A number of genes expressed by the somatic cell lineages were reduced in the betaglycan null testis. Notably, a significant reduction in the expression of a fetal Leydig cell marker, Insl3, was detected in null testis as early as 12.5 dpc, and this reduction was sustained through 14.5 dpc (Fig. 3A) . In addition, reduced expression of the Sertoli cell markers Sox9, Dhh, and Amh and the somatic cell marker Nr5a1 (previously known as Sf1) were decreased approximately 50% at 14.5 dpc (P , 0.05; Fig. 3 , B-E), with downward trends in Amh and Dhh expression also observed at 12.5 and 13.5 dpc (Fig. 3, B and C). In contrast, the level of expression of Pou5f1 (previously known as Oct4), which is expressed exclusively in the fetal gonad by the germ cell lineage, was not significantly different in wild-type, heterozygous, and null testes (Fig. 3F) . These data indicate that development of the PHENOTYPE OF BETAGLYCAN NULL TESTIS somatic cell lineages in fetal testis are selectively disrupted in the absence of betaglycan.
To determine if the abnormalities in betaglycan knockout testis that were detected at 12.5 dpc had their origin earlier in gonad development, the expression of genes implicated in bipotential gonad development were examined by qRT-PCR in the betaglycan wild-type, heterozygous, and knockout embryos. No significant differences in the levels of expression of the sex determination genes Sry, Sox9, Wt1, Nr5a1, and Nr0b1 (previously known as Dax1) were detected in 11.5 dpc urogenital ridge (data not shown), indicating that the disruption to testis development in null mice begins after the bipotential gonad phase.
Betaglycan Null Testis Exhibits Reduced Fetal Leydig Cell Function
Since betaglycan is predominantly expressed by testis interstitial cells such as the fetal Leydig cells between 12.5 to 14.5 dpc [16] , the levels of expression of genes involved in differentiated Leydig cell function, i.e., steroidogenesis, were quantitated in the betaglycan null mice using qRT-PCR to 156 determine if steroidogenic output is compromised in the null testis. A key protein in steroidogenesis is the steroidogenic acute regulatory protein (STAR), which facilitates the rapid transport of cholesterol into mitochondria, where the conversion of cholesterol to pregnenolone is catalyzed by CYP11A1. The action of HSD3B1 converts pregnenolone to progesterone while CYP17A1 catalyzes the conversion of progesterone or pregnenolone into hydroxyprogesterone [28] . The expression levels of these genes were significantly lower in the betaglycan null testis at 12.5, 13.5, and 14.5 dpc by 50%-70% (P , 0.001; Fig. 4 ). In addition, the heterozygous testis exhibited downward trends in the expression of Star, Cyp11a1, and Hsd3b1 at 12.5-13.5 dpc, which only reached significance for Cyp11a1 at 13.5 dpc (P , 0.05). Whole mount in situ hybridization analysis confirmed that the level of expression of Cyp11a1 was reduced in betaglycan null testis from 13.5 to 14.5 dpc, although the pattern of expression in the null and heterozygote testes were similar to wild-type (Fig. 5, A-C) . In 
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157 agreement with the real-time PCR data, the heterozygotes exhibited reduced Cyp11a1 expression in whole mount that was intermediate between null and wild-type gonads (Fig. 5 , A-C).
Leydig Cell Numbers Unchanged in the Betaglycan Null Testis
Using a morphometric analysis on testis sections at 14.5 dpc, Leydig cells were counted in every tenth slide through each gonad. Two of the three knockouts exhibited reduced total testis area/section compared to their wild-type littermates (66% and 44% reduction, respectively; Fig. 6A ). Accordingly, both total cord area/section and total interstitial area/section were also reduced in the same two knockout littermates (Fig. 6, B  and C) . However, when corrected to total testis area, none of the null gonads exhibited a difference in the percentage of interstitium to total testis area/section compared to their wildtype controls (Fig. 6D) . Importantly, fetal Leydig cell numbers per total interstitial area or per total gonad area were not changed in null gonads (Fig. 6, E and F) .
DISCUSSION
During normal male gonad development in the mouse, several events occur downstream of Sry expression at 11.5 dpc including cell proliferation, migration, and differentiation. These lead to rapid formation of structures characteristic of the testis, most notably the testis cords and the vasculature at around 12.0-12.5 dpc. Sertoli cells, the key support cells for the germ cells, differentiate and aggregate around the germ cells. Peritubular myoid cells associate with the Sertoli cells   FIG. 3 . Betaglycan null testis exhibits quantitative changes in somatic but not germ cell markers at 12.5-14.5 dpc. The expression levels of cell type-specific genes were analyzed by qRT-PCR in 12.5, 13.5, and 14.5 dpc wild-type, heterozygous, and betaglycan null gonads and normalized to 18S rRNA (Rn18s). Leydig cell marker Insl3 (A); Sertoli cell markers Sox9 (B), Dhh (C), and Amh (D); the somatic cell marker Nr5a1 (E); and the primordial germ cell marker Pou5f1 (F) were examined in all the ages tested. Means 6 SEM from representative assays are shown. *P , 0.05, **P , 0.01, ***P , 0.001.
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and establish a basal lamina. This basal lamina delineates the cords, composed of Sertoli, myoid, and germ cells, from the interstitium, which contains stromal and pre-Leydig cells (for full review, see [29] ). The present study demonstrates that a deficiency in betaglycan results in a disruption to the establishment of testis architecture at around 12.5 dpc. We detected molecular and cellular differences in somatic cell types within the null testis between 12.5 to 14.5 dpc, but no changes in germ cell markers. We also detected no changes in molecular markers prior to 12.5 dpc in the null testis. Collectively, these data indicate that betaglycan is essential to the regulation of somatic cell events involved in cord formation after Sry has initiated the male-specific development pathway.
We hypothesize that betaglycan influences the differentiation, functioning, and interactions of key somatic cell types within the fetal testis by modulating the actions of its ligands, the TGFBs and inhibins. TGFB superfamily members have been shown to be locally produced within specific cell types of the developing rodent testis [30] [31] [32] [33] . TGFB1, TGFB2, and TGFB3 isoforms are all produced in the fetal rodent testis and could act in an autocrine or paracrine manner to regulate cord formation [34] [35] [36] . In support of this, the type I and type II receptors for the TGFBs have been detected on fetal Leydig, FIG. 4 . Reduction in the expression of genes involved in steroidogenesis in the betaglycan null fetal testis. The expression levels of Star (A), Cyp11a1 (B), Hsd3b1 (C), and Cyp17a1 (D) were determined by qRT-PCR in 12.5, 13.5, and 14.5 dpc wild-type, heterozygous, and betaglycan null gonads. Gene expression levels were normalized to 18S rRNA (Rn18s). Bars represent mean 6 SEM of three individual pools of RNA. *P , 0.05, ***P , 0.001.
FIG. 5. Betaglycan null testis exhibits normal distribution of Leydig cells.
Whole mount in situ hybridization analysis of Cyp11a1 expression on fetal mesonephros-gonad complexes dissected from 12.5 to 14.5 dpc wild-type (A), heterozygous (B), and knockout (C) embryos was conducted using riboprobes against Cyp11a1. The scale bar is the same for all images. Bar ¼ 50 lm.
PHENOTYPE OF BETAGLYCAN NULL TESTIS peritubular, and germ cells [37] . Limited information is available on the actions of the TGFB superfamily during fetal testis development as knockout mice generally exhibit embryonic or neonatal lethality (for review, see [38] ). In addition, none of the TGFB ligand knockout mice have been examined during the early period of gonadogenesis, i.e., 12.5-14.5 dpc, immediately following sex determination. However, it has been reported that Tgfb2 null mutant mice exhibit testis agenesis and ectopia at birth [6] and a decrease in the number of seminiferous cords at 15 dpc [8] . In contrast, a decrease in the number of germ cells was noted in the TGFB1 null testis at the day of birth [8] . These data are in broad agreement with in vitro studies, which showed that TGFB1 reduces migration and growth of peritubular cells [39] and cord formation [34] . Furthermore, addition of exogenous TGFB2 enhances aggregation of Sertoli cells in cocultures with peritubular myoid cells from 19-day-old rats but not in monocultures [37] . Collectively, the data suggest that TGFB1 and TGFB2 secretion by somatic cells may act on both somatic and germ cells of the fetal testis to regulate cord formation. The presence of betaglycan on peritubular cells and other interstitial cells in fetal testis [16] would be expected to enhance the actions of the TGFBs on these somatic cell types [29] , and thereby betaglycan may play a role in establishing a morphogen gradient within the fetal testis. In particular, the presence of betaglycan on peritubular cells may be essential for the proper deposition of the fetal testis basal lamina, an integral structural element of the forming seminiferous cords, which we found to be disrupted in the betaglycan null testis. In addition, the presence of betaglycan on interstitial cells appears essential to maintain normal somatic cell number, as shown by the significant reduction in proliferating cells within the testis interstitium at 14.5 dpc. This may have an indirect impact on cell numbers within the seminiferous cords as well since we observed a downward trend in proliferating cells within the cords at the same age. These data are in accordance with our morphometric data on the 14.5 dpc testis, which showed that two of the three knockout testes examined were reduced in overall size compared to their wild-type littermates. Although Inhba and Inha gene expression has been shown to be upregulated in fetal rodent testis following sex determination and to be involved in late-gestation epididymal coiling [7, 32, 40] , specific roles for these factors in cord formation during the period of early gonadogenesis have yet to be established.
In addition to testis dysgenesis, fetal Leydig cell development was disrupted in the betaglycan null testis. Fetal Leydig cell markers (Insl3, Cyp11a1, Star, Hsd3b1, and Cyp17a1) were significantly reduced in the betaglycan null testis starting as early as 12.5 dpc, prior to molecular changes in any other fetal gonad cell type. In addition, the heterozygous testis exhibited a reduction in Cyp11a1 expression that was midway between the betaglycan null and wild-type levels. This suggests that the requirement for betaglycan on fetal Leydig cells is dosage-dependent and that even a 50% reduction in betaglycan expression significantly affects fetal Leydig cell development. Because pre-Sertoli cell migration, differentiation, and proliferation are crucial for proper testis development [41] , and paracrine signals such as DHH from the pre-Sertoli cells initiate fetal Leydig cell differentiation [42] , it is possible that a problem in the development of somatic cell precursors may precede the Leydig cell phenotype. However, the Sertoli cell markers Dhh, Sox9, and Amh did not exhibit reduced expression until 13.5-14.5 dpc, suggesting that the disruption to fetal testis steroidogenic capacity observed in null embryos FIG. 6 . Morphometric analysis of 14.5 dpc fetal testis. Morphometric analyses were undertaken on CYP11A1-immunostained testis sections from three betaglycan wildtype and null littermate pairs (1-3) at 14.5 dpc to determine changes in Leydig cell number. Data are shown by littermate pair for mean total testis area/section (A); mean total cord area/section (B); mean total interstitial area/section (C); percentage of interstitial to total testis area/section (D); mean total Leydig cell numbers per total interstitial area (E); and mean total Leydig cell number per total testis area (F). *P , 0.05.
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is the direct result of disrupted betaglycan signaling in fetal Leydig cells rather than disrupted paracrine signaling from Sertoli cells. This conclusion is supported by the finding that the expression level of Nr5a1, one of the earliest markers of somatic cells and a key regulator of steroidogenic enzyme expression [43] , was also not significantly reduced in betaglycan null testis until 14.5 dpc. Thus, reduced fetal Leydig cell development appears to be a primary testis phenotype in betaglycan null mice, not secondary to defects in precursor somatic cells. Because fetal murine Sertoli cells lack betaglycan expression [16] , the reduced expression of Sertoli cell markers that occurs in 14.5 dpc null testis is likely secondary to changes within the fetal testis interstitium, rather than a direct effect of betaglycan loss on Sertoli cell development.
Fetal Leydig cells are potentially important direct targets for the TGFB superfamily of growth factors. Type I and type II TGFB and activin receptors, as well as betaglycan, have been detected on fetal Leydig cells in fetal rat and human testis [4, 16, 35] . In vitro, TGFBs, activins, and inhibins have been reported to regulate Leydig cell number and steroidogenesis [36, 44] , indicating that this family of growth factors may be integral to establishing testis endocrine function. However, to our knowledge, no other study has assessed the TGFB superfamily actions on early fetal Leydig cell development. Our data suggest that it is differentiated fetal Leydig cell function, rather than proliferation or death, that is affected by the absence of betaglycan. Notably, Leydig cell number was unchanged in the betaglycan null testis at 14.5 dpc. Interestingly, the reduced expression of several steroidogenic pathway genes in betaglycan null testis was sustained until at least 14.5 dpc despite the recovery of testicular structure and the maintenance of Leydig cell numbers. Reduced expression of the genes involved in steroidogenesis would be expected to compromise the steroidogenic capacity of the fetal testis, which in term would compromise the masculinization of the fetus [45] . In addition, reduced expression of Leydig cell-derived Insl3 has been shown to result in the failure of proper testis descent in mice [46] . The sustained reduction in steroidogenic capacity in the betaglycan null testis is in keeping with recent studies in rodent models, which found that the development of the fetal rat testis endocrine system was most susceptible to disruption during early gonadogenesis, shortly after sex determination occurs [47] . Disruptions during this period of gonad development were sustained and had long-term repercussions on the development of the male reproductive tract [48, 49] , which suggests that disruption of the betaglycan gene may similarly have a long-term impact on the testis endocrine function. The current results may therefore have relevance to testis dysgenesis syndrome in humans in which a deficiency in androgen production or function in fetal Leydig cells is believed to underlie the development of downstream sexual disorders [3] . Betaglycan has also been reported in the human fetal testis exclusively in the interstitium and peritubular cells [4] , in agreement with what we observed in the mouse [16] . However, the impact of betaglycan on human testis development is not currently known because betaglycan function cannot be directly examined in human fetal testis. The betaglycan knockout mouse embryos represent an excellent model to study the functional interactions of the members of TGFB superfamily and their role in fetal testis development.
